Ionis appoints Ludwig Hantson, biopharmaceutical executive, to Board of Directors
Ionis Pharmaceuticals announced the appointment of Ludwig Hantson, Ph.D., a veteran biopharma executive with 30+ years of experience including CEO roles at Alexion and Baxalta, to its Board of Directors effective immediately. The appointment strengthens board expertise as Ionis prepares for multiple commercial launches and accelerated growth.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day